Hit discovery for GPCRs: HTS or virtual screens?
16 June 2021 By Beacon Discovery
Join us live and learn from an industry expert regarding GPCR virtual screening approaches and challenges and much more.
List view / Grid view
Webinars
Filter the results
Paradigm Shift in Drug Discovery: Discover Small Molecule Degraders Using E3scan™ Technology Platform
6 May 2021 By Eurofins Discovery
Book your place for our free webinar and learn about how targeted protein degradation (TPD) utilises small molecules to hijack the cellular degradation machinery through the recruitment of E3 ubiquitin ligases to proteins of interest.
The discovery and challenges of antibodies targeting GPCRs
20 April 2021 By Domain Therapeutics
Register for our webinar which will focus on the progress achieved in G protein-coupled receptor (GPCR) therapeutic antibody-based discovery and development.
Bead Assisted Mass Spectrometry assay platform for targeted proteomics
15 April 2021 By Bruker Scientific, LLC
Sign up for our free webinar that will focus on the detailed description of the workflow and case studies of BAMS™ assays developed for targets relevant to neurology and virology.
Novel small molecule inhibitors of oncogenic SHP2 variants characterised by cellular target engagement
ON-DEMAND By Eurofins DiscoverX & Sanford Burnham Prebys Discovery
In this on-demand webinar industry experts discuss how the InCELL Pulse technology provides a valuable tool for the discovery and characterisation of novel SHP2 inhibitors.
High content screening reveals the phenotypic landscape of intestinal organoid regeneration
ON-DEMAND By Yokogawa Life Innovations
Watch our on-demand webinar and learn how image-based phenotypic screening relies on extraction of multivariate information from cells cultured in a large number of screened conditions. In this webinar, we explore the application of complex and biologically relevant model systems for drug screening, such as small intestinal organoids.
CRISPR screening to identify new drug targets in regulatory B cells and other immune cells
ON-DEMAND By Horizon Discovery
Watch our on-demand webinar where we discuss how CRISPR screening is proving to be a robust platform for the identification and validation of new biological targets for disease treatment. It is hoped that CRISPR screens will accelerate drug development by providing more robust targets for validation than siRNA screens, for…
New methods towards efficient and high-throughput drug-target screening
ON-DEMAND By Living Systems Institute, University of Exeter
Watch our on-demand webinar where we explore new methods to improve data quality from high-throughput screens. You'll learn about solutions for common problems in drug-target discovery and our keynote speaker will also look at case studies where new approaches to screening have identified high-quality candidate drugs for proliferative diseases.
SARS-CoV-2 testing: automation of high-throughput qPCR and COVID-seq
ON-DEMAND By SPT Labtech
In this on-demand webinar, we explored the various methods of COVID-19 testing: qPCR, COVID-seq, antigen and antibody detection, and others. Coupling these assays with low volume, high speed automation has made great strides toward achieving the high-throughput testing essential to ending this pandemic.
Next generation strategies for cancer immunotherapy
ON-DEMAND By PerkinElmer
During this on-demand webinar, two leading researchers will discuss their innovative approaches to developing novel opportunities for immunotherapy treatments.
Untangling gene expression complexity with pooled CRISPR screens coupled to single-cell transcriptome analysis
ON-DEMAND By Horizon Discovery
During this on-demand webinar we present data showing how Horizon’s CRISPRsc screening platform offers a streamlined approach to elucidating valuable and intriguing biological information that is critical to resolving complex biological questions.
Mobile phase optimisation for oligonucleotide analytical methods by LC-MS
ON-DEMAND By Phenomenex
In this on-demand webinar, we provide an overview of nucleic acid therapeutics and discuss the chromatographic challenges associated with oligonucleotides. We also explore modulation of the mobile phase additives alkylamine ion pair and perfluorinated alcohols. Finally, we will show how optimisation of mobile phase can improve not only chromatographic performance…
Drug repurposing approaches to fast track development of new therapies for COVID-19
ON-DEMAND By Tecan
This webinar described the recent efforts to identify small molecule therapeutics for the treatment of SARS-CoV-2 infection and COVID-19 disease.
Improving cell-based assays and their future in drug discovery
ON-DEMAND By Horizon Discovery
Watch our on-demand webinar with Horizon Discovery which summarises the challenges in translating promising pre-clinical therapeutic candidates into clinical success.
Cell-based Surface Plasmon Resonance with AstraZeneca
ON-DEMAND By Biosensing Instrument
In this webinar, we will provide an overview of the technology with some application examples and also see a case study how AstraZeneca is exploring SPRM for studies on G-protein-coupled receptors (GPCR) in close collaboration with Biosensing Instrument.